Calendula officinalis for Health & Longevity - Quick Reference Sheet

Calendula officinalis for Health & Longevity

Created on 07/22/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A time-honored topical herb whose credible benefits are almost entirely at the skin level: speeding healing of minor wounds and easing irritated skin, with weaker support for diaper rash, post-childbirth wounds, and vaginal yeast irritation. Its radiation-skin use is unsettled. No human support exists for longevity when swallowed; external use is safe, though daisy-family allergy is the main concern. (Full Review)

Protocol

Application
Topical, 2–3× daily
Ointment, cream, or gel standardized to ~2–10% flower extract
Preparation
Match vehicle to skin
Ointments/oils for dry skin; gels/creams for weeping or inflamed areas
Radiation Skin Care
After each session
Applied after each radiotherapy session and continued between sessions
Time to effect
Wound Closure
1–2 weeks
Measurable wound-closure differences reported in trials
Soothing
Within days
For minor wounds and irritation
Radiation Dermatitis
Over weeks
Emerges across a radiotherapy course, where present

Benefits

Contraindications
  • Known Asteraceae/Compositae allergy (ragweed, daisies, chrysanthemums, marigolds, arnica)
  • Internal use in pregnancy (all trimesters) and lactation
  • Internal use when trying to conceive
Key Interactions
  • Sedatives / CNS depressants (benzodiazepines, Z-drugs), internal use
  • Antihypertensives (ACE inhibitors, calcium-channel blockers), internal use
  • Other topical actives on the same skin (acids, retinoids)
  • Sedating or blood-sugar-lowering supplements (valerian, kava, melatonin)
  • Radiotherapy (coordinate topical timing with care team)

Risk & Side Effects

  • High: [risks_high]
  • Medium: Allergic contact dermatitis and Asteraceae cross-sensitivity
  • Low: Oral/internal use during pregnancy; additive sedation and blood-pressure lowering
  • Speculative: Systemic toxicity from high-dose oral use; interference with fertility

Monitoring

Marker Target Why
Skin patch-test response (48 h) No redness, itching, or swelling Detects Asteraceae allergy before broader use
Local wound/dermatitis grade Improving over 1–2 weeks Tracks whether the target skin condition responds
hs-CRP < 1.0 mg/L Body-wide inflammation marker; relevant only if used internally
Fasting blood glucose 70–85 mg/dL Screens for the animal-only blood-sugar-lowering signal if used internally

Cadence: Condition-driven; reassess treated skin at ~1 week and 2 weeks. Internal-use markers every 6–12 months.

Qualitative Assessment

  • Faster visible closure or drying of a minor wound
  • Reduced redness, itching, or burning in irritated or inflamed skin
  • Comfort during a radiotherapy course (less skin soreness), where applicable
  • Absence of any allergic or irritant reaction at the application site